ZA200703277B - Novel pyrimidine compounds, process for their preparation and compositions containing them - Google Patents
Novel pyrimidine compounds, process for their preparation and compositions containing themInfo
- Publication number
- ZA200703277B ZA200703277B ZA200703277A ZA200703277A ZA200703277B ZA 200703277 B ZA200703277 B ZA 200703277B ZA 200703277 A ZA200703277 A ZA 200703277A ZA 200703277 A ZA200703277 A ZA 200703277A ZA 200703277 B ZA200703277 B ZA 200703277B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- compositions containing
- pyrimidine compounds
- novel pyrimidine
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
- C07D239/40—One sulfur atom as doubly bound sulfur atom or as unsubstituted mercapto radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61237404P | 2004-09-23 | 2004-09-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200703277B true ZA200703277B (en) | 2008-06-25 |
Family
ID=36090705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200703277A ZA200703277B (en) | 2004-09-23 | 2007-04-20 | Novel pyrimidine compounds, process for their preparation and compositions containing them |
Country Status (9)
Country | Link |
---|---|
US (2) | US7820654B2 (ru) |
EP (2) | EP1805142A4 (ru) |
JP (1) | JP2008538544A (ru) |
AU (2) | AU2005286593A1 (ru) |
CA (2) | CA2581454A1 (ru) |
IL (1) | IL182121A0 (ru) |
RU (1) | RU2007110731A (ru) |
WO (2) | WO2006034474A2 (ru) |
ZA (1) | ZA200703277B (ru) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GT200500284A (es) * | 2004-10-15 | 2006-03-27 | Aventis Pharma Inc | Pirimidinas como antagonistas del receptor de prostaglandina d2 |
GB0520657D0 (en) | 2005-10-11 | 2005-11-16 | Ludwig Inst Cancer Res | Pharmaceutical compounds |
MX2008014450A (es) * | 2006-05-18 | 2009-03-09 | Mannkind Corp | Inhibidores de cinasa intracelular. |
WO2007143724A2 (en) * | 2006-06-07 | 2007-12-13 | Reddy Us Therapeutics, Inc. | Compositions and methods to enhance reverse cholesterol transport |
WO2008122378A1 (en) * | 2007-04-04 | 2008-10-16 | Ucb Pharma, S.A. | Novel pyridine derivatives, processes for preparing them, pharmaceutical compositions thereof |
WO2008137533A1 (en) * | 2007-05-04 | 2008-11-13 | Reddy Us Therapeutics, Inc. | Methods and compositions for upregulation of gata activity |
CN104327084B (zh) | 2007-11-28 | 2017-06-06 | 达那-法伯癌症研究所 | Bcr‑abl的小分子豆蔻酸酯抑制剂及其使用方法 |
TW200948362A (en) | 2008-04-09 | 2009-12-01 | Mitsubishi Tanabe Pharma Corp | New compounds and their uses |
US11351168B1 (en) | 2008-06-27 | 2022-06-07 | Celgene Car Llc | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
US8338439B2 (en) | 2008-06-27 | 2012-12-25 | Celgene Avilomics Research, Inc. | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
CA2986640C (en) | 2008-06-27 | 2019-03-26 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
WO2010085246A1 (en) * | 2009-01-21 | 2010-07-29 | Praecis Pharmaceuticals Inc | 2,4-diamino-1,3,5-triazine and 4, 6-diamino-pyrimidine derivatives and their use as aggrecanase inhibitors |
MX346801B (es) | 2009-03-13 | 2017-03-31 | Agios Pharmaceuticals Inc | Métodos y composiciones para trastornos relacionados con la proliferación celular. |
WO2010129053A2 (en) | 2009-05-05 | 2010-11-11 | Dana Farber Cancer Institute | Egfr inhibitors and methods of treating disorders |
MX2012000256A (es) | 2009-06-29 | 2012-04-19 | Agios Pharmaceuticals Inc | Compuestos terapeuticos y composiciones. |
EP3064595B1 (en) | 2009-10-21 | 2019-02-27 | Agios Pharmaceuticals, Inc. | Methods for cell-proliferation-related disorders |
US8563568B2 (en) | 2010-08-10 | 2013-10-22 | Celgene Avilomics Research, Inc. | Besylate salt of a BTK inhibitor |
MY181898A (en) | 2010-11-01 | 2021-01-12 | Celgene Car Llc | Heterocyclic compounds and uses thereof |
JP5956999B2 (ja) | 2010-11-01 | 2016-07-27 | セルジーン アヴィロミクス リサーチ, インコーポレイテッド | ヘテロアリール化合物およびその使用 |
EP2637502B1 (en) | 2010-11-10 | 2018-01-10 | Celgene CAR LLC | Mutant-selective egfr inhibitors and uses thereof |
ES2675903T3 (es) | 2011-05-03 | 2018-07-13 | Agios Pharmaceuticals, Inc. | Activadores de piruvato quinasa para uso en terapia |
CN102827073A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
CN102827170A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
AR088570A1 (es) | 2011-10-28 | 2014-06-18 | Celgene Avilomics Res Inc | Metodos para tratar una enfermedad o trastorno relacionado con la tirosina quinasa de bruton |
JP6411895B2 (ja) | 2012-01-06 | 2018-10-24 | アジオス ファーマシューティカルズ, インコーポレイテッド | 治療活性化合物およびその使用方法 |
US9474779B2 (en) | 2012-01-19 | 2016-10-25 | Agios Pharmaceuticals, Inc. | Therapeutically active compositions and their methods of use |
ES2880109T3 (es) | 2012-03-15 | 2021-11-23 | Celgene Car Llc | Formas sólidas de un inhibidor de la cinasa del receptor del factor de crecimiento epidérmico |
PL2825042T3 (pl) | 2012-03-15 | 2019-02-28 | Celgene Car Llc | Sole inhibitora kinazy receptora czynnika wzrostu naskórka |
EP2906212A4 (en) | 2012-10-15 | 2016-06-08 | Agios Pharmaceuticals Inc | THERAPEUTIC COMPOUNDS AND COMPOSITIONS |
WO2014100748A1 (en) | 2012-12-21 | 2014-06-26 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
CN103896856B (zh) * | 2012-12-25 | 2016-06-08 | 叶龙 | 一种多取代单环嘧啶类jnk激酶抑制剂及其制备方法和用途 |
US9561228B2 (en) | 2013-02-08 | 2017-02-07 | Celgene Avilomics Research, Inc. | ERK inhibitors and uses thereof |
US8877766B2 (en) * | 2013-02-15 | 2014-11-04 | Peter F. Kador | Neuroprotective multifunctional antioxidants and their monofunctional analogs |
WO2015003355A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
WO2015003360A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
US9579324B2 (en) | 2013-07-11 | 2017-02-28 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
JP6529492B2 (ja) * | 2013-07-11 | 2019-06-12 | アジオス ファーマシューティカルズ, インコーポレイテッド | 癌の処置のためのidh2突然変異体阻害剤としての2,4−または4,6−ジアミノピリミジン化合物 |
WO2015006592A1 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as idh2 mutants inhibitors for the treatment of cancer |
US20150031627A1 (en) | 2013-07-25 | 2015-01-29 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
US9492471B2 (en) | 2013-08-27 | 2016-11-15 | Celgene Avilomics Research, Inc. | Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase |
US9415049B2 (en) | 2013-12-20 | 2016-08-16 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
CA2942072C (en) | 2014-03-14 | 2022-07-26 | Agios Pharmaceuticals, Inc. | Pharmaceutical compositions and use of (s)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-( 4-cyanopyridin-2-yl)-n-( 5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide |
JP2015178576A (ja) * | 2014-03-19 | 2015-10-08 | 富士フイルム株式会社 | 化合物、着色組成物、インクジェット記録用インク、インクジェット記録方法、インクジェットプリンタカートリッジ、及びインクジェット記録物 |
DK3179858T3 (da) | 2014-08-13 | 2019-07-22 | Celgene Car Llc | Forme og sammensætninger af en ERK-inhibitor |
CN105777653A (zh) * | 2014-12-26 | 2016-07-20 | 中国科学院上海药物研究所 | 用作Lp-PLA2抑制剂的嘧啶酮类化合物及其药物组合物 |
US11234976B2 (en) | 2015-06-11 | 2022-02-01 | Agios Pharmaceuticals, Inc. | Methods of using pyruvate kinase activators |
UA123400C2 (uk) | 2015-10-15 | 2021-03-31 | Аджиос Фармасьютікалз, Інк. | Комбінована терапія для лікування злоякісних пухлин |
KR20180061372A (ko) | 2015-10-15 | 2018-06-07 | 아지오스 파마슈티컬스 아이엔씨. | 악성 종양의 치료를 위한 조합물 요법 |
US10774064B2 (en) | 2016-06-02 | 2020-09-15 | Cadent Therapeutics, Inc. | Potassium channel modulators |
CN107782805B (zh) * | 2016-08-25 | 2021-02-02 | 亚宝药业集团股份有限公司 | 一种双嘧达莫合成的关键中间体杂质hplc分析方法 |
TW201819376A (zh) | 2016-10-06 | 2018-06-01 | 比利時商健生藥品公司 | 經取代之1H-咪唑並[4,5-b]吡啶-2(3H)-酮及其作為GLUN2B受體調節劑之用途 |
EP3571193B1 (en) | 2017-01-23 | 2021-12-01 | Cadent Therapeutics, Inc. | Potassium channel modulators |
CZ308052B6 (cs) * | 2017-05-24 | 2019-11-20 | Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v. v. i. | Polysubstituované pyrimidiny |
JP7346441B2 (ja) | 2018-04-04 | 2023-09-19 | ヤンセン ファーマシューティカ エヌ.ベー. | 置換ピリジン及びピリミジン並びにglun2b受容体調節物質としてのそれらの使用 |
US10980788B2 (en) | 2018-06-08 | 2021-04-20 | Agios Pharmaceuticals, Inc. | Therapy for treating malignancies |
AU2020292994A1 (en) | 2019-06-14 | 2022-01-06 | Janssen Pharmaceutica Nv | Substituted pyrazolo-pyrazines and their use as GluN2B receptor modulators |
US11530210B2 (en) | 2019-06-14 | 2022-12-20 | Janssen Pharmaceutica Nv | Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulators |
JP2022538795A (ja) | 2019-06-14 | 2022-09-06 | ヤンセン ファーマシューティカ エヌ.ベー. | ピラジンカルバメート及びGluN2B受容体調節因子としての使用 |
CA3142996A1 (en) | 2019-06-14 | 2020-12-17 | Janssen Pharmaceutica Nv | Substituted pyrazolo-pyridine amides and their use as glun2b receptor modulators |
CN114007691A (zh) | 2019-06-14 | 2022-02-01 | 詹森药业有限公司 | 吡啶氨基甲酸酯及其作为GluN2B受体调节剂的用途 |
WO2020249791A1 (en) | 2019-06-14 | 2020-12-17 | Janssen Pharmaceutica Nv | SUBSTITUTED PYRAZOLO[4,3-b]PYRIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS |
US10702525B1 (en) | 2019-09-04 | 2020-07-07 | United Arab Emirates University | Pyrimidine derivatives as anti-diabetic agents |
CN115417825A (zh) * | 2022-08-15 | 2022-12-02 | 山东大学 | 一种五元或六元稠环并嘧啶类环丙基萘衍生物及其制备方法与应用 |
Family Cites Families (124)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR8201305A (pt) * | 1981-03-16 | 1983-01-25 | Sterling Drug Inc | Processo de preparacao de piridinas substituidas sistema de duplicacao sem carbono sensivel a pressao |
ES2078890T3 (es) | 1986-10-09 | 1996-01-01 | Upjohn Co | Amino esteroides en c20 a c26. |
US4980350A (en) | 1988-02-25 | 1990-12-25 | Merck & Co., Inc. | Piperazinylalkylpyrimidines as hypoglycemic agents |
GB8817315D0 (en) | 1988-07-20 | 1988-08-24 | Pfizer Ltd | Triazole antifungal agents |
ES2014560A6 (es) | 1988-12-30 | 1990-07-16 | Marga Investigacion | Proceso para la preparacion de un nuevo reactivo organo-sililpolifosforico y su aplicacion al proceso de sontesis de 3-carboxi-quinolonas o azaquinolonas y sus sales. |
JPH02235054A (ja) | 1989-03-09 | 1990-09-18 | Fuji Photo Film Co Ltd | ハロゲン化銀カラー写真感光材料 |
US5023258A (en) | 1989-06-20 | 1991-06-11 | Pfizer Inc. | Triazole antifungal agents |
US5179123A (en) | 1989-12-18 | 1993-01-12 | G. D. Searle & Co. | LTB4 synthesis inhibitors |
JPH03206450A (ja) | 1990-01-09 | 1991-09-09 | Fuji Photo Film Co Ltd | 新規な色素形成カプラー及びそれを用いたハロゲン化銀カラー写真感光材料及びその処理方法 |
JP2515162B2 (ja) | 1990-02-23 | 1996-07-10 | 富士写真フイルム株式会社 | メチン化合物 |
US6559186B1 (en) | 1990-02-26 | 2003-05-06 | Arc 1, Inc. | Compositions and methods of treatment of sympathetically maintained pain |
DE4011361A1 (de) | 1990-04-07 | 1991-10-10 | Bayer Ag | 2-aryl-6-hetarylpyridin-derivate |
GB9008818D0 (en) | 1990-04-19 | 1990-06-13 | Ici Plc | Amine derivatives |
US5124154A (en) | 1990-06-12 | 1992-06-23 | Insite Vision Incorporated | Aminosteroids for ophthalmic use |
US5256408A (en) | 1990-06-12 | 1993-10-26 | Insite Vision Incorporated | Aminosteroids for ophthalmic use |
US5155166A (en) | 1990-06-18 | 1992-10-13 | Eastman Kodak Company | Use of 1-(1-pyrrolidinylcarbonyl)pyridinium salts to attach compounds to carboxylated particles and a kit containing same |
DE4020257A1 (de) * | 1990-06-26 | 1992-01-02 | Bayer Ag | 2,6-diarylpyridin-derivate |
DE4038721A1 (de) | 1990-12-05 | 1992-06-11 | Bayer Ag | Mittel zum schutz von pflanzen gegen befall durch mikroorganismen |
DE69230387T2 (de) | 1991-04-22 | 2000-06-29 | Fuji Photo Film Co Ltd | Photographische Silberhalogenidmaterialien und Verfahren zu ihrer Verarbeitung |
EP0517542B1 (en) | 1991-06-05 | 1995-08-30 | Sumitomo Chemical Company Limited | Organic electroluminescence devices |
CA2074864A1 (en) | 1991-07-30 | 1993-01-31 | Carmen Almansa | Tetralones with pharmacological activity |
US5149699A (en) | 1991-10-24 | 1992-09-22 | American Home Products Corporation | Substituted pyridopyrimidines useful as antgiotensin II antagonists |
US5336677A (en) | 1991-10-24 | 1994-08-09 | American Home Products Corporation | Substituted aminopyrimidines as antihypertensives |
EP0610265B1 (en) | 1991-11-01 | 1996-12-27 | PHARMACIA & UPJOHN COMPANY | Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents |
JP3082373B2 (ja) | 1991-11-08 | 2000-08-28 | 日本曹達株式会社 | 新規ピリジニウム塩化合物及び重合開始剤 |
JP3067351B2 (ja) | 1991-11-08 | 2000-07-17 | 日本曹達株式会社 | 新規ピリジニウム塩化合物及び重合開始剤 |
US5387747A (en) | 1992-02-24 | 1995-02-07 | Laboratoires Upsa | Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present |
FR2687676B1 (fr) | 1992-02-24 | 1994-07-08 | Union Pharma Scient Appl | Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant. |
HUT64323A (en) | 1992-06-09 | 1993-12-28 | Richter Gedeon Vegyeszet | Process for production new piperazinyl-bis(alkyl-amino)-pyrimidine derivatives |
HU209678B (en) | 1992-06-09 | 1994-10-28 | Richter Gedeon Vegyeszet | Process for producing biologically active eburnamenin-14-carbonyl-amino derivatives and pharmaceutical compositions containing them |
EP0578103B1 (en) | 1992-06-29 | 1998-11-04 | Fuji Photo Film Co., Ltd. | Silver halide photographic material |
EP0662962A1 (en) | 1992-09-28 | 1995-07-19 | Pfizer Inc. | Substituted pyrimidines for control of diabetic complications |
US5374514A (en) | 1993-01-06 | 1994-12-20 | Kirk; Mark P. | Photothermographic materials |
JPH06240163A (ja) | 1993-02-18 | 1994-08-30 | Fuji Photo Film Co Ltd | トリメチン色素の製造方法 |
US5681954A (en) | 1993-05-14 | 1997-10-28 | Daiichi Pharmaceutical Co., Ltd. | Piperazine derivatives |
RU2124511C1 (ru) | 1993-05-14 | 1999-01-10 | Фармасьютикал Ко., Лтд | Производные пиперазина |
WO1994027604A1 (fr) * | 1993-05-28 | 1994-12-08 | Taisho Pharmaceutical Co., Ltd. | Utilisation medicale d'un derive de pyridine |
ES2212797T3 (es) | 1993-08-19 | 2004-08-01 | Janssen Pharmaceutica N.V. | Derivados de dihidrobenzopirano vasoconstrictores. |
HU222275B1 (hu) | 1993-08-19 | 2003-05-28 | Janssen Pharmaceutica N.V. | Érszűkítő hatású szubsztituált aril-oxi-alkil-diaminok, ezek előállítási eljárása, valamint hatóanyagként ilyen vegyületeket tartalmazó gyógyszerkészítmények |
JP3102228B2 (ja) | 1993-10-01 | 2000-10-23 | 富士レビオ株式会社 | パーオキシダーゼ活性測定用試薬及びそれを用いた測定方法 |
JPH07179771A (ja) | 1993-11-09 | 1995-07-18 | Fuji Photo Film Co Ltd | トリメチン色素の製造方法 |
US6004719A (en) * | 1994-04-25 | 1999-12-21 | Polaroid Corporation | Imaging medium and process for producing an image |
CN1152907A (zh) | 1994-06-10 | 1997-06-25 | 生化学工业株式会社 | 2-酰胺基丙醇化合物及其药物组合物 |
DE4425660A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | 7-substituierte 1-[4-(1H-1,2,4-triazol-1-yl-methyl)phenyl] substituierte Chinoloncarbonsäuren |
US5559108A (en) | 1994-09-02 | 1996-09-24 | Bristol-Myers Squibb Company | Cephalosporin derivatives |
DE4431821A1 (de) | 1994-09-07 | 1996-03-14 | Bayer Ag | Verfahren zur Herstellung von N-Arylaminoacrylsäurederivaten und die Verwendung so hergestellter N-Arylaminoacrylsäurederivate zur Herstellung von 4-Chinolon-3-carbonsäurederivaten |
US5559135A (en) | 1994-09-14 | 1996-09-24 | Merck & Co., Inc. | Endothelin antagonists bearing pyridyl amides |
JPH08110635A (ja) | 1994-10-07 | 1996-04-30 | Shin Etsu Chem Co Ltd | 化学増幅ポジ型レジスト材料 |
JPH08225535A (ja) | 1994-11-15 | 1996-09-03 | Dai Ichi Seiyaku Co Ltd | インダゾール誘導体 |
US5451486A (en) | 1994-11-22 | 1995-09-19 | Sun Chemical Corporation | Photographic contrast promoting agents |
US5922743A (en) * | 1994-11-28 | 1999-07-13 | Taisho Pharmaceutical Co., Ltd. | Pyridine derivative |
JPH08175993A (ja) | 1994-12-21 | 1996-07-09 | Green Cross Corp:The | 抗酸化剤 |
GB2297747B (en) | 1995-02-07 | 1998-11-11 | Ilford Ag | Novel hydrazides |
TW446706B (en) | 1995-02-07 | 2001-07-21 | Janssen Pharmaceutica Nv | Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines, a pharmaceutical composition containing them, their intermediates and a process for their preparation |
DE69630214T2 (de) | 1995-03-10 | 2004-07-15 | Berlex Laboratories, Inc., Richmond | Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien |
US5514505A (en) | 1995-05-15 | 1996-05-07 | Xerox Corporation | Method for obtaining improved image contrast in migration imaging members |
DK0992501T3 (da) | 1995-09-22 | 2002-10-28 | Wakunaga Pharma Co Ltd | Pyridoncarboxylsyre derivater som antibakterielle midler |
NO965193L (no) | 1995-12-08 | 1997-06-09 | Seikagaku Kogyo Kk Seikagaku C | Aminalkoholderivat og fremgangsmåte for fremstilling derav |
US5977117A (en) | 1996-01-05 | 1999-11-02 | Texas Biotechnology Corporation | Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin |
JPH09194582A (ja) | 1996-01-19 | 1997-07-29 | Idemitsu Petrochem Co Ltd | ポリカーボネートの製造方法 |
US5696282A (en) | 1996-03-26 | 1997-12-09 | Phillips Petroleum Company | Process for producing organosulfur compounds |
TW440563B (en) | 1996-05-23 | 2001-06-16 | Hoffmann La Roche | Aryl pyrimidine derivatives and a pharmaceutical composition thereof |
US5952349A (en) | 1996-07-10 | 1999-09-14 | Schering Corporation | Muscarinic antagonists for treating memory loss |
US5977138A (en) | 1996-08-15 | 1999-11-02 | Schering Corporation | Ether muscarinic antagonists |
US6008234A (en) | 1996-09-12 | 1999-12-28 | Berlex Laboratories, Inc. | Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants |
KR20000048899A (ko) | 1996-10-04 | 2000-07-25 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | 1,4-디치환 피페라진 |
EP0937065A1 (en) | 1996-10-31 | 1999-08-25 | Novo Nordisk A/S | Constrained somatostatin agonists and antagonists |
JPH10153838A (ja) | 1996-11-22 | 1998-06-09 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料の処理方法 |
JP3720931B2 (ja) | 1996-11-26 | 2005-11-30 | 富士写真フイルム株式会社 | ハロゲン化銀写真感光材料の処理方法 |
SK81299A3 (en) | 1996-12-20 | 2000-01-18 | Byk Gulden Lomberg Chem Fab | Imidazopyridazine compounds, pharmaceutical composition containing the same and their use |
JPH10207019A (ja) | 1997-01-22 | 1998-08-07 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料の処理方法 |
US6432947B1 (en) | 1997-02-19 | 2002-08-13 | Berlex Laboratories, Inc. | N-heterocyclic derivatives as NOS inhibitors |
ES2189142T3 (es) | 1997-02-21 | 2003-07-01 | Bayer Ag | Arilsulfonamidas y sus analogos y su uso en el tratamiento de enfermedades neurodegenerativas. |
JPH10260512A (ja) | 1997-03-19 | 1998-09-29 | Fuji Photo Film Co Ltd | ハロゲン化銀感光材料の処理方法 |
US6251900B1 (en) | 1997-07-24 | 2001-06-26 | Zenyaku Kogyo Kabushiki Kaisha | Heterocyclic compounds and antitumor agent containing the same as active ingredient |
DE19831246A1 (de) | 1998-07-11 | 2000-01-13 | Clariant Gmbh | Verfahren zur Herstellung von Arylpyridinen |
ID28273A (id) | 1998-08-10 | 2001-05-10 | Partnership Of Michael E Garst | Prodrug inhibitor pompa proton |
US6093734A (en) | 1998-08-10 | 2000-07-25 | Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin | Prodrugs of proton pump inhibitors |
US6972287B1 (en) | 1999-06-10 | 2005-12-06 | Pfizer Inc. | Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
SE9903610D0 (sv) * | 1999-10-06 | 1999-10-06 | Astra Ab | Novel compounds II |
US6897225B1 (en) | 1999-10-20 | 2005-05-24 | Tanabe Seiyaku Co., Ltd. | Inhibitors of αLβ2 mediated cell adhesion |
GB9924862D0 (en) * | 1999-10-20 | 1999-12-22 | Celltech Therapeutics Ltd | Chemical compounds |
US6906067B2 (en) | 1999-12-28 | 2005-06-14 | Bristol-Myers Squibb Company | N-heterocyclic inhibitors of TNF-α expression |
NZ520241A (en) | 2000-02-25 | 2004-05-28 | F | Adenosine receptor modulators |
AU2001242629B2 (en) * | 2000-03-29 | 2005-08-11 | Cyclacel Limited | 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
US20040092552A1 (en) | 2000-04-25 | 2004-05-13 | Brown David L | 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation |
EP1226127B1 (en) | 2000-05-04 | 2009-07-01 | Basf Se | Substituted phenyl sulfamoyl carboxamides |
CY2010012I2 (el) | 2000-05-25 | 2020-05-29 | Novartis Ag | Μιμητικα θρομβοποιητινης |
JP2004502692A (ja) | 2000-07-04 | 2004-01-29 | ニューロサーチ、アクティーゼルスカブ | アリール及びヘテロアリールジアザビシクロアルカン類、その製造方法及びその使用方法 |
US6767671B2 (en) | 2000-07-14 | 2004-07-27 | Mitsubishi Chemical Corporation | Non-aqueous electrolytic solution and secondary battery containing same |
EP2224790B1 (en) | 2000-07-17 | 2013-01-02 | UDC Ireland Limited | Light emitting element and azole compound |
JP4922539B2 (ja) * | 2000-09-15 | 2012-04-25 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼインヒビターとして有用なピラゾール化合物 |
EP1202608B2 (en) | 2000-10-30 | 2012-02-08 | Kabushiki Kaisha Toyota Chuo Kenkyusho | Organic light-emitting devices |
DE10060412A1 (de) | 2000-12-05 | 2002-06-06 | Bayer Ag | DELTA1-Pyrroline |
WO2002047690A1 (en) | 2000-12-12 | 2002-06-20 | Cytovia, Inc. | Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
US6693295B2 (en) | 2000-12-25 | 2004-02-17 | Fuji Photo Film Co., Ltd. | Indole derivative, material for light-emitting device and light-emitting device using the same |
AU2002243036A1 (en) | 2001-04-09 | 2002-10-28 | Fuji Photo Film Co., Ltd. | Azo compounds and process of producing the same and novel intermediate compounds used in the process of producing azo compounds |
US6673818B2 (en) | 2001-04-20 | 2004-01-06 | Pharmacia Corporation | Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation |
WO2002088079A2 (en) * | 2001-05-01 | 2002-11-07 | Bristol-Myers Squibb Company | Dual inhibitors of pde 7 and pde 4 |
JP4510442B2 (ja) | 2001-06-26 | 2010-07-21 | ブリストル−マイヤーズ スクイブ カンパニー | TNF−α発現のN−ヘテロ環インヒビター |
AR035087A1 (es) | 2001-08-09 | 2004-04-14 | Syngenta Participations Ag | Piridil-alquinos y piridil-n-oxido-alquinos herbicidas activos, procedimiento para su preparacion, composicion herbicida y para inhibir el crecimiento de plantas, metodo para el control del crecimiento de plantas indeseables , y metodo para la inhibicion del crecimiento de plantas |
WO2003030909A1 (en) | 2001-09-25 | 2003-04-17 | Bayer Pharmaceuticals Corporation | 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer |
US20030187026A1 (en) | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
EP1321169A1 (en) | 2001-12-18 | 2003-06-25 | Biofrontera Pharmaceuticals AG | Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament |
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
WO2003075828A2 (en) | 2002-03-11 | 2003-09-18 | Zetiq Technologies Ltd. | Compounds useful in the treatment of cancer |
US20040110757A1 (en) | 2002-03-21 | 2004-06-10 | Thomas Arrhenius | Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis |
US20030205696A1 (en) | 2002-04-25 | 2003-11-06 | Canon Kabushiki Kaisha | Carbazole-based materials for guest-host electroluminescent systems |
US6864261B2 (en) | 2002-05-02 | 2005-03-08 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
AU2003245669A1 (en) | 2002-06-21 | 2004-01-06 | Cellular Genomics, Inc. | Certain aromatic monocycles as kinase modulators |
CN1678321A (zh) | 2002-07-29 | 2005-10-05 | 里格尔药品股份有限公司 | 用2,4-嘧啶二胺化合物治疗或者预防自体免疫性疾病的方法 |
NZ537952A (en) | 2002-08-08 | 2008-04-30 | Amgen Inc | Vanilloid receptor ligands and their use in treatments |
US7419984B2 (en) | 2002-10-17 | 2008-09-02 | Cell Therapeutics, Inc. | Pyrimidines and uses thereof |
CN1187341C (zh) | 2002-10-28 | 2005-02-02 | 武汉大学 | N-羟基脒类化合物及其制备方法 |
CN1173952C (zh) | 2002-10-28 | 2004-11-03 | 武汉大学 | 一种n-羟基脒类化合物的制备方法 |
ES2412273T3 (es) | 2002-11-21 | 2013-07-10 | Novartis Ag | Inhibidores de 2-morfolín-4-pirimidinas como inhibidores de fosfotidilinositol (PI) 3-quinasa y su uso en el tratamiento del cáncer. |
JP4707082B2 (ja) | 2002-11-26 | 2011-06-22 | コニカミノルタホールディングス株式会社 | 有機エレクトロルミネッセンス素子および表示装置 |
US20050014753A1 (en) | 2003-04-04 | 2005-01-20 | Irm Llc | Novel compounds and compositions as protein kinase inhibitors |
US6875781B2 (en) | 2003-04-04 | 2005-04-05 | Cell Therapeutics, Inc. | Pyridines and uses thereof |
US6872833B2 (en) | 2003-04-14 | 2005-03-29 | Hoffmann-La Roche Inc. | Adenosine receptor ligands |
GB2404855A (en) | 2003-07-07 | 2005-02-16 | Pantherix Ltd | Arylcarboxylic acid derivatives and their therapeutic use |
CN1823048A (zh) | 2003-07-15 | 2006-08-23 | 神经能质公司 | 作为类香草醇受体配位体的经取代的嘧啶-4-基胺类似物 |
AU2004261484A1 (en) | 2003-07-30 | 2005-02-10 | Cyclacel Limited | 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
US8455489B2 (en) | 2003-11-10 | 2013-06-04 | Exelixis, Inc. | Substituted pyrimidine compositions and methods of use |
-
2005
- 2005-09-23 US US11/234,695 patent/US7820654B2/en not_active Expired - Fee Related
- 2005-09-23 WO PCT/US2005/034244 patent/WO2006034474A2/en active Application Filing
- 2005-09-23 EP EP05812252A patent/EP1805142A4/en not_active Withdrawn
- 2005-09-23 RU RU2007110731/04A patent/RU2007110731A/ru not_active Application Discontinuation
- 2005-09-23 WO PCT/US2005/034243 patent/WO2006034473A2/en active Application Filing
- 2005-09-23 JP JP2007533673A patent/JP2008538544A/ja not_active Withdrawn
- 2005-09-23 AU AU2005286593A patent/AU2005286593A1/en not_active Abandoned
- 2005-09-23 AU AU2005286592A patent/AU2005286592A1/en not_active Abandoned
- 2005-09-23 CA CA002581454A patent/CA2581454A1/en not_active Abandoned
- 2005-09-23 CA CA002581623A patent/CA2581623A1/en not_active Abandoned
- 2005-09-23 EP EP05799686A patent/EP1796673A2/en not_active Withdrawn
- 2005-09-23 US US11/234,257 patent/US7622486B2/en not_active Expired - Fee Related
-
2007
- 2007-03-22 IL IL182121A patent/IL182121A0/en unknown
- 2007-04-20 ZA ZA200703277A patent/ZA200703277B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
RU2007110731A (ru) | 2008-10-27 |
US7820654B2 (en) | 2010-10-26 |
US7622486B2 (en) | 2009-11-24 |
IL182121A0 (en) | 2007-07-24 |
WO2006034474A2 (en) | 2006-03-30 |
WO2006034473A2 (en) | 2006-03-30 |
CA2581454A1 (en) | 2006-03-30 |
WO2006034474A3 (en) | 2007-05-18 |
JP2008538544A (ja) | 2008-10-30 |
US20060084645A1 (en) | 2006-04-20 |
EP1796673A2 (en) | 2007-06-20 |
US20060084644A1 (en) | 2006-04-20 |
CA2581623A1 (en) | 2006-03-30 |
EP1805142A2 (en) | 2007-07-11 |
AU2005286592A1 (en) | 2006-03-30 |
WO2006034473A3 (en) | 2006-12-14 |
AU2005286593A1 (en) | 2006-03-30 |
EP1805142A4 (en) | 2009-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200703277B (en) | Novel pyrimidine compounds, process for their preparation and compositions containing them | |
EP1814885A4 (en) | NOVEL HETEROCYCLIC BICYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SAME | |
HK1209729A1 (en) | Compounds, compositions and methods | |
HUP0400405A3 (en) | Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates | |
SI2210872T1 (sl) | Nova kristalinična oblika iii agomelatina, postopek za njeno pripravo in farmacevtski sestavki, ki jo vsebujejo | |
ME02026B (me) | Novi kristalni v oblik agomelatina, postupak za njegovu proizvodnju i farmaceutske smiješe koje ga sadrže | |
IL186523A0 (en) | Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof | |
IL210756A0 (en) | Carbostyril compound, process for their preparation and pharmaceutical compositions containing them | |
HK1112916A1 (en) | 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof 3- | |
EP1797078A4 (en) | BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THESE DERIVATIVES, PREPARATION AND USES THEREOF | |
IL179530A0 (en) | Novel compounds, pharmaceutical compositions containing same and methods of use for same | |
HK1096386A1 (en) | Indanyl-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
HUP0401522A2 (en) | New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation | |
ZA200603810B (en) | Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1126190A1 (en) | Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them | |
HK1096097A1 (en) | Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
IL176993A0 (en) | Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof | |
EP1797074A4 (en) | COMPOUNDS, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND APPLICATIONS THEREOF IIII | |
ZA200501010B (en) | BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them. | |
IL178960A0 (en) | Process for the preparation of pyridin-2-ylmethylsulphinyl-1h-benzimidazol compounds | |
HU0500126D0 (en) | New compounds and process for their preparation | |
ZA200702047B (en) | Compounds, compositions containing them, preparation thereof and uses thereof III | |
IL182021A0 (en) | Compounds, compositions containing them, preparations thereof and uses thereof |